TALK KEYWORD INDEX
This page contains an index consisting of author-provided keywords.
1 | |
137Cs | |
155Tb | |
3 | |
3D bioprinting | |
3D cell cultures | |
3D liver bioscaffolds | |
3D spheroids | |
4 | |
4-MU | |
47Sc cross section | |
5 | |
53BP1 | |
6 | |
6-thio-dG | |
A | |
A549 lung carcinoma | |
Abdominal aorta | |
abscopal effect | |
Accelerated ions | |
accident dosimetry | |
Acute Radiation Syndrome | |
AD | |
Adipose-derived stem cells | |
adverse outcome pathways | |
agonist | |
agrospace | |
alpha particles | |
Alpha radiation | |
alternative tumor models | |
Aneurysm | |
anthocyanins | |
Antioxidant defense | |
AOPs | |
ApcMin/+ mouse | |
apoptosis | |
apoptosis inhibition | |
aquatic biota | |
ATAC-seq | |
Atherosclerosis | |
atlas | |
automatic scoring | |
B | |
beam monitoring | |
beam quality assurance | |
Beta amyloid | |
BIANCA | |
Biodistribution | |
Biodosimetry | |
biofortification | |
Biological Dosimetry | |
biological effects | |
biological response | |
biomarker | |
biomarkers | |
Biomolecules | |
biophysical model | |
Biophysical Modeling | |
BNCT | |
Bomber effect | |
boost radiotherapy | |
boron | |
Boron-Neutron Capture Therapy | |
brachytherapy | |
breast cancer | |
Breast Cancer Cells | |
breast cancer radiotherapy | |
building material | |
Bystander effects | |
C | |
caldera | |
Campania | |
Campi Flegrei | |
Cancer | |
cancer cells | |
cancer model | |
cancer risk | |
Cancer stem cell | |
Cancer Stem Cells | |
cancer therapy | |
carbon ion irradiation | |
carbon ions | |
carboplatin | |
Carcinogenesis | |
cardiovascular disease | |
CBMN assay | |
CBNM | |
cdc2 | |
cell biology | |
cell cycle | |
cell cycle distribution | |
cell cycle progression | |
Cell death | |
Cell freezing/thawing | |
Cell Therapy | |
cell-cycle evaluation | |
cGAS | |
checkpoint kinase 1 | |
Chernobyl exclusion zone | |
childhood cancer survivors | |
Chondrosarcoma | |
chromatid breaks | |
Chromosomal aberration | |
chromosomal aberrations | |
Chronic low doses | |
Cigarette smoke | |
Circulating Tumor Cells | |
clinical beam | |
Clinical implementation | |
clonogenic assay | |
clonogenic survival | |
cognitive risks | |
colon cancer | |
Colorectal cancer | |
communication | |
concentration factors | |
confocal | |
coralyne | |
cosmic radiation | |
Cultural Heritage | |
Curcumin | |
CW/PW | |
cyclotron-based radiopharmaceuticals | |
CZT | |
D | |
DAP3 | |
Data Hub | |
DDR inhibitors | |
deep-learning | |
development of countermeasures | |
diatom | |
dicentric chromosome assay | |
direct and indirect effects | |
DMSO | |
DNA damage | |
DNA damage and repair | |
DNA damage response | |
DNA methylation | |
DNA repair | |
DNA/chromatin damage | |
dose and dose rate effectiveness factor (DDREF) | |
dose monitoring | |
Dose-rate | |
dosimetric audit | |
dosimetric properties | |
dosimetry | |
DOTATATE | |
drug delivery | |
dSTORM | |
E | |
early and late effects | |
electromagnetic exposure | |
electromagnetic sensitivity | |
Elephants | |
Embryogenesis | |
EMF/RF-EMF | |
Energy metabolism | |
Environmental radioactivity | |
Evolutionary Biology | |
exosomes | |
Experimental and simulated data | |
exposure evaluation | |
Extracellular vesicle | |
extracellular vesicles | |
F | |
FBPA | |
ferritin | |
fibroblasts | |
filtration | |
FLASH | |
FLASH irradiation | |
FLASH mechanism | |
FLASH Proton Therapy | |
FLASH radiotherapy | |
FLUKA Monte Carlo | |
fluorescent in situ hybridization (FISH) | |
fractionated radiotherapy | |
G | |
G-quadruplex ligand | |
G2 arrest | |
G2 chromosomal radiosensitvity assay | |
G2-M checkpoint | |
Gafchromic EBT3 film | |
galactic cosmic ray solar modulation | |
gamma irradiation | |
gamma radiation | |
Geant4 | |
Geant4-DNA | |
gene and protein expression | |
gene expression | |
Gene Expression Profile | |
genetics | |
genomic instability | |
Genotoxicity | |
GEP-NET | |
GIS | |
Glioblastoma | |
gold nanoparticles | |
gold nanorods | |
GPU | |
GRID irradiation | |
H | |
H2AX | |
Hadrontherapy | |
hairy root cultures | |
HAS3 | |
head and neck | |
head and neck cancer | |
head and neck cancer cells | |
head and neck cancer patients | |
health professionals | |
heavy ion radiobiology | |
heavy ions | |
helium ions | |
hematological effects | |
hibernation | |
high dose-rates | |
High LET | |
high LET radiation | |
high-LET | |
high-resolution microscopy | |
Histone deacetylase inhibitors (HDACi) | |
human blood | |
Human space exploration | |
Human Spaceflight | |
hyaluronan | |
hyaluronic acid | |
Hydroxyl radical | |
Hyper-radiosensitivity | |
I | |
image guidance | |
Immune cell recruitment | |
immune dysfunction | |
Immune escape | |
immune modulation | |
immune phenotyping | |
immune response | |
immune system | |
immunohistochemistry | |
immunotherapy | |
IMPT | |
in vitro | |
in vitro measurements | |
in vivo studies | |
individual variation | |
Induced radioresistance | |
Inflammation | |
instillation | |
Intercellular communication | |
Interphase nucleus | |
Intestinal cancer | |
Intestine | |
intra- and intercellular sensitivity | |
iodine | |
ion imaging | |
ionisation cluster size distribution | |
Ionising radiation | |
Ionizing radiation | |
ionizing radiation-induced (repair) foci (IRIF) chromatin micro and nano-architecture | |
Ionizing Radiation-Induced Foci (IRIFs) | |
ionizing radiations | |
IORT | |
irradiation | |
J | |
Juvenile | |
K | |
kidney cancer | |
KRAS mutation | |
L | |
Laser accelerated beams | |
LET | |
Leukaemia | |
Leukemia | |
Linear-quadratic model | |
live-cell imaging | |
live-cell phase-contrast-microscopy | |
localization microscopy | |
localized radiation injury | |
low and high LET | |
low dose | |
low dose rate | |
Low doses | |
Low LET | |
low LET radiation | |
Low-dose fractionated radiation | |
Low-dose radiation | |
low-energy protons | |
luminescence methods | |
Lunar Gateway | |
Lutathera | |
Lymphocytes | |
M | |
manganese | |
Mathematical modelling | |
MCMC-tracking | |
mechanistic investigation | |
Medical countermeasure | |
MEDIRAD EARLY-HEART cohort | |
Metabolism | |
metabolism alteration | |
metabolomics | |
metal nanoparticles (MP) | |
mice | |
micro-PET/CT | |
Microbeam Radiation Therapy | |
Microbeam radiotherapy | |
Microdosimetric Kinetic Model | |
Microdosimetry | |
Microenvironment | |
Microglia | |
Microglial cells | |
microgravity | |
micronuclei | |
micronucleus assay | |
microRNA | |
microscopy | |
MicroTom | |
Microtubules | |
migration | |
miRNA | |
Mitochondria | |
mixed beams | |
modelling | |
modifiable risk factors | |
Molecular effects | |
molecular imaging | |
Monocytes | |
Monte Carlo | |
Monte Carlo Simulation | |
Monte Carlo simulations | |
MonteCarlo | |
mouse imaging | |
MRT | |
mucosal melanoma | |
multimodal data integration | |
Mutation induction | |
N | |
nano-systems | |
nanodiamonds | |
nanodosimetry | |
nanoparticle-enhanced cancer radiotherapy | |
Nanoparticles | |
nanoparticles internalization | |
NBS1 foci | |
NCT | |
Neuroblastoma | |
Nicotine | |
non-human biota | |
non-invasive biomarkers | |
non-ionizing exposure | |
Non-Ionizing Radiation | |
non-reference dosimetry | |
non-targeted effects | |
Normal tissue sparing | |
Normal tissue toxicity | |
Nrf2 | |
NSCLC | |
NTCP | |
nuclear medicine | |
nuclear reaction modeling | |
O | |
occupational exposure | |
Olfactory function | |
Online range verification | |
Organoids | |
Oxidative stress | |
oxidized protein | |
oxygen effect | |
P | |
p21 | |
paclitaxel | |
pancreatic carcinoma | |
PARP inhibitor | |
Parp1 | |
Particle therapy | |
patients | |
Payloads | |
PBCT | |
percentage depth dose distribution | |
peripheral blood lymphocytes | |
persistence homology | |
PET | |
Peto’s Paradox | |
photons | |
phytoplankton | |
plasma | |
PPAR alpha | |
PRDM1 | |
Preclinical research | |
pregnancy | |
preservation | |
primary immunodeficiencies | |
prompt gamma | |
prostate cancer | |
proteasome | |
Protein glycosylation | |
proteins | |
proteomics | |
Proton Boron Capture Therapy | |
Proton Irradiation | |
proton minibeam radiotherapy | |
proton therapy | |
proton tomography | |
Proton-Boron-Fluorine Enhanced Protontherapy (PBFEPT) | |
protons | |
protons irradiations | |
protontherapy | |
PRRT | |
psoriasis | |
psychological stress | |
R | |
Radiation | |
Radiation Chemistry | |
radiation effects | |
radiation exposure | |
radiation physics | |
radiation protection | |
Radiation response | |
radiation risk | |
radiation sensitivity | |
radiation susceptibility | |
radiation therapy | |
radiation-induced effects | |
radiation-risk mitigation | |
radio-induced damage | |
radio-induced DNA damage | |
radioactive contamination | |
Radioactive Ion Beams | |
radiobilogical effects | |
radiobiological hypoxia | |
radiobiology | |
radiocommunication networks | |
radioconjugates | |
radiolabeling | |
radiology | |
Radiolysis | |
radiomics | |
Radiomitigation | |
radionuclide therapy | |
radiopharmaceutical | |
Radioprotection | |
radioprotective agents | |
Radioresistance | |
radioresistant cancer cells | |
radioresistant tumors | |
radiosensitivity | |
Radiosensitization | |
radiosensitizers | |
Radiotherapy | |
Radiotherapy damage | |
radiotherapy photon beams | |
Radon | |
radon indoor | |
radon map | |
Radon progeny | |
Radon solubility | |
radon therapy | |
Raman spectroscopy | |
RBE | |
relative biological effectiveness | |
resin process | |
Resistance to therapy | |
Retrospective dosimetry | |
RF-EMF | |
RHPS4 | |
Ripley´s distance statistics | |
risk assessment | |
RNA sequencing | |
RNA-binding protein | |
RNA-Sequencing Analysis | |
RNAseq | |
robotic space exploration | |
ROS distribution | |
Rradionuclide therapy | |
S | |
scRNA-seq | |
second cancer | |
Secondary cancer | |
Sexes | |
side-effects | |
signal transduction | |
silicon carbide detector | |
simulation | |
simulation models | |
single-molecule localization microscopy (SMLM) | |
solar physics | |
somatostatin | |
Somatostatin analogues | |
space exploration | |
space radiation | |
space radiation research | |
Space Weather | |
spaceflight | |
Spatial radiotherapy | |
Spatially fractionated radiation therapy | |
Stealth effect | |
Stem cells | |
stopping power | |
strain imaging | |
Stromal vascular fraction | |
sub-cellular dosimetry | |
Synergic effects | |
synthetic torpor | |
systems biology | |
T | |
tandem accelerator | |
TBI | |
telomerase | |
Telomere | |
telomeres | |
theragnostic | |
theranostics | |
thermoluminescence | |
time series | |
tissues radioresponse | |
TLD | |
tomography | |
TOPAS | |
Total Body Irradiation | |
TP53 | |
TPS | |
Track Structure | |
Transcription | |
Translation | |
TRAX-Chem | |
Treatment Plan | |
treatment planning | |
treatment verification | |
Triple Negative Breast Cancer | |
Tritium | |
Tumor cell radiosensitization | |
Tumor cells | |
Tumor cryoablation | |
tumor hypoxia | |
Tumor microenvironment | |
Tumour response | |
U | |
U2OS | |
Ultra high dose rate | |
Ultra-high dose rate | |
Uranium | |
V | |
V79 | |
Vascular endothelium | |
vascular system | |
VE-821 | |
W | |
Water radiolysis | |
workers safety | |
X | |
X-ray beam quality | |
X-rays | |
Xenografted mice | |
Y | |
Yield of hydrated electron | |
Z | |
Zebrafish | |
zinc | |
α | |
α+γ spectrometry | |
α-spectrometry | |
γ | |
γ-H2AX foci assay | |
γH2AX foci |